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CMR Evaluation of Cardiac
Involvement During the
Convalescence of
Kawasaki Disease
Kawasaki disease (KD) is a form of vasculitis affecting both the
myocardium and coronary arteries. Coronary aneurysms de-
velop in 15% to 25% of untreated patients (1,2). Myocardial
inflammation is nearly universal during the acute phase (100%
of cases in both post-mortem analysis and myocardial biopsy).
However, there are no data about cardiac involvement during
the convalescence of KD (1,2). Our aim was to evaluate the
heart during the convalescence of KD by cardiac magnetic
resonance (CMR). Thirteen KD patients, 6 to 8 years of age
who fulfilled the currently used criteria for KD diagnosis, were
evaluated by CMR 20 to 40 days after the onset of the disease.
Patients were treated with high-dose immunoglobulin within
the first 10 days of fever and responded well. Troponin I levels
were normal in all except 1 patient, who had ST-segment
elevation in II, III, and aVF. Patients were re-evaluated by
CMR 3 months later.
Coronary arteries were examined using a 3-dimensional
segmented k-space gradient-echo sequence (echo time: 2.1 ms,
repetition time: 7.5 ms, flip angle: 30°, slice thickness: 1.5
mm). Inflammation evaluation was performed using short tau
inversion recovery T2-weighted analysis, early gadolinium
enhancement (EGE), and late gadolinium enhancement
(LGE) (contrast-enhanced fast spin echo T1-weighted mag-
netic resonance, flip angle: 15°, echo time: 1.4 ms, repetition
time: 5.5 ms, inversion time: 225 to 275 ms as individually
optimized to null myocardial signal). Left ventricular systolic
function was evaluated using short-axis steady-state free-
precession sequence.
The average length of continuously visualized left main
coronary artery with left anterior descending coronary artery
(LAD), left circumflex coronary artery, and right coronary
artery (RCA) by magnetic resonance angiography was 5.2 
0.8 cm, 4.2  1.0 cm, and 9.9  1.2 cm, respectively. The left
circumflex coronary artery diameter was 2.01  0.17 mm, the
LAD was 3.7  0.2 mm, and the RCA was 3.80  0.09 mm.
Coronary artery ectasia (defined as diffuse, uniform luminal
dilation between 1.50- to 2.0-fold larger than maximal normal
diameter of the respective vessel [1]) was documented in all
patients in the LAD and RCA, but not in the left circumflex
coronary artery. Discrete, coronary aneurysms (defined as
segmental dilation between 1.50- to 2.0-fold larger than
maximal normal diameter of the respective vessel [1]) were
assessed in 2 patients. An RCA aneurysm (5.5 mm in
diameter and 9.5 mm in length) in 1 patient and a LADaneurysm in another patient (7.5 mm in diameter and 10.5
mm in length) also were identified. Significant stenosis was
not detected in any of them. Myocardial inflammation was
documented in 6 (46%) of 13 patients. Although statistical
evaluation could not be performed because of the small
number of patients, in short tau inversion recovery T2-
weighted analysis and EGE, the signal ratio was extremely
high in KD with inflammation compared with age-matched
controls (2.94  0.20 vs. 1.38  0.12 and 28.62  2.48 vs.
2.95 0.21, respectively). The increase in absolute myocardial
enhancement in EGE was 160% to 200%. The high values of
T2-weighted analysis and EGE in these patients probably
were the result of the active inflammatory process early during
the course of the disease (examination time: 20 to 25 days after
disease onset). The LGE areas were identified in only 3 of 6
patients with myocardial inflammation. A transmural, inferior
myocardial infarction in the territory of an RCA aneurysm was
assessed in 1 patient (Figs. 1 and 2). Left ventricular ejection
fraction was lower in patients with inflammation compared
with those without inflammation (left ventricular ejection fraction
49.83 1.16% vs. 62.28  1.70%, p  0.001). No correlation
between the presence of coronary aneurysms and myocardial
inflammation was documented. CMR re-evaluation of pa-
tients 3 months later revealed regression of inflammation in
all, whereas coronary ectasia remained unchanged in 5 of 13
patients.
Scarce data exist that are referred to cases with severe left
ventricular dysfunction (3–5). Furthermore, there are not
Figure 1. Coronary Magnetic Resonance Angiography Image
Coronary magnetic resonance angiography image showing a right
coronary artery aneurysm (arrow).
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Letters to the Editor 1141enough data about CMR for inflammation evaluation in KD. Our
findings were in agreement with previous clinical studies supporting
the high incidence of myocarditis during stages II and III (days 12
to 25 and days 25 to 40, respectively) and in older patients. In our
patients with myocardial inflammation, both T2-weighted analysis
and EGE were highly suggestive of inflammatory process. The lack
of LGE in one-half of the patients was not a surprising finding. In
contrast to viral myocarditis, which is considered to be the result of
injury by virus infiltration and the host’s immune response, the
myocarditis in KD is characterized by inflammatory infiltration
from the coronary arteries to the interstitial myocardium, and
therefore the myocardial necrosis is not observed frequently, which
may explain the lack of LGE and the rapid clinical improvement of
our cases (5).
Another important finding was the presence of ectasia, but not
aneurysm, in all KD patients. This is probably because the early
administration of immunoglobulin decreased the incidence of
coronary aneurysms (1). However, myocardial inflammation was a
common finding, with rapid recovery in the subsequent 3 months.
The current study has the following limitations: 1) the small
number of patients, older than the usual age for KD; 2) infants with
severe myocardial disease were not included; 3) long-term CMR
follow-up was not available; and 4) myocardial biopsy was not
available because of the benign presentation of the disease, which
did not allow an invasive procedure.
In conclusion, coronary ectasia and myocardial inflammation are
common findings during the convalescence of KD, but usually have
a benign prognosis. Myocardial infarction and coronary aneurysms
occasionally can be found, although immunoglobulin was admin-
istered during the early phase of the disease. A single comprehen-
sive CMR examination applied in KD during convalescence may
provide important diagnostic information on myocardial inflamma-
tion and coronary anatomy, and thus may be helpful for therapeutic
decision making. However, further studies are needed to confirm
Figure 2. Viability Image
Viability image showing a transmural, inferior myocardial infarction (arrow)
in the same patient shown in Figure 1.these findings in larger samples.Sophie Mavrogeni, MD,* Konstantinos Bratis, MD,
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Prosthetic Heart Valve
Ring Thrombosis
Despite being mechanical and prosthetic, heart valve rings (HVR) are
known to have a lower risk of thrombosis compared with prosthetic
mechanical heart valves, thus anticoagulation therapy is only recom-
mended within 3 months after the surgery according to the current
guidelines (1). We present 4 cases in whichHVR thrombi were obtained
by transesophageal echocardiography (TEE) as a novel finding with
HVR.
The first case was a 41-year-old woman who had a mitral HVR
operation 3 months before her admission with acute atrial fibrillation
and who was a candidate for electrical cardioversion. She was referred for
TEE to exclude the presence of left atrial (LA) thrombus when we
incidentally observed multiple hyperechogenic, mobile thrombus images
on the prostheticmitral ring (Sorin ring, number: 34, SorinGroup,Milan,
Italy) (Fig. 1A, Online Video 1A). Her international normalized ratio
(INR) was effective (2.6) on admission. As a result of having a history of
embolic stroke 1 year previously, the patient was given a low-dose (25mg),
slow-infusion (6 h) tissue-type plasminogen activator (TPA)without bolus
administration 2 times (for a total of 50mg), and as a result, TEE showed
an unsatisfactory regression in the thrombi (Fig. 1B, Online Video 1B).
We decided to follow up the patient under effective anticoagulation
because she refused both the repeat dose of TPA and choice of surgery.
The second case was a 61-year-old woman who had mitral valve
replacement (ATS, number: 27, ATS Medical, Inc., Minneapolis, Min-
